Soleno Therapeutics stock has surged over 1,500% since September 2023, driven by the progress and today's FDA approval of ...

Stock analysts at HC Wainwright decreased their Q1 2025 earnings per share estimates for shares of Rhythm Pharmaceuticals in ...

Setmelanotide is a melanocortin-4 receptor (MC4R) agonist designed to treat hyperphagia a New registry study to focus on impact of fatigue in people with craniopharyngiomaBOSTON, March 18 ...

At close: March 27 at 4:00:01 PM EDT ...